Back to today’s briefing

Story perspectives

FDA Reduces Animal Testing, Embraces Ethical Drug Innovation

7/3/2025

49 9

Summary

Story summary

The FDA's groundbreaking decision to cut back on mandatory animal testing signals a transformative moment in drug development. By embracing New Approach Methodologies (NAMs) such as organoids and computational models, this shift not only prioritizes scientific integrity but also champions the ethical treatment of animals, paving the way for safer and more innovative drug testing practices.

1 of 1

Story summary

The FDA's groundbreaking decision to cut back on mandatory animal testing signals a transformative moment in drug development. By embracing New Approach Methodologies (NAMs) such as organoids and computational models, this shift not only prioritizes scientific integrity but also champions the ethical treatment of animals, paving the way for safer and more innovative drug testing practices.